Descrizione Clinica
Muscle pain Miotens contractures and dol sch Miotens
MIOTENS CONTRACTS AND ONLY 0.25% CUTANEA
active ingredients
100 ml, as a solution, contain: Active ingredient: tiocolchicoside 0.25 g Excipients: propylene glycol For the full list of excipients, see paragraph 6.1
Excellent
Polysorbed 80, propylene glycol, ethyl alcohol, propylene glycol dipelargonate, benzilic alcohol, monohydrate monobasic phosphate sodium, dodecaidrate dibasic phosphate, Nerolene lavender, purified water. Propellent: propane-butane mixture (propane/n- butano/iso-butane).
Therapeutic indications
Lombo-sciatalgie (backache), cervical-brachial neuralgies (sweet and neck-to-back contracture, shoulder and upper limbs), obstinate twists, post-traumatic and postoperative painful syndromes.
Contraindications
Hypersensitivity to the active ingredient or any of the excipients. Flaccid paralysis, muscle hypotonies. Pregnancy and nursing (cf. 4.6).
Population
Apply a quantity of foam according to the size of the area that must be treated 2-3 times a day. Treatment can be associated with physical-rehabilitative therapies. Method of administration: shake before use and press the dispenser by holding the container overturned.
Conservation
MIOTENS CONTRACTS AND DOLORE 0.25% skin foam: keep away from heat. Contains flammable propellant. Do not expose at temperatures above 50°C.
Warnings
Posology should be properly reduced in case of side effects. The use, especially if prolonged, of products for topical use can give rise to phenomena of sensitization. If they occur, it is necessary to stop treatment and establish suitable therapy. MIOTENS Contains propylene glycol: it can cause skin irritation.
Interactions
No notes.
Effects
Cases of rash and skin rash are reported. See also paragraph 4.4.
Overdosing
No known or overdose cases have been reported in literature.
Although a teratogenic effect has not been observed in animal studies except when thiocolchicoside has been administered at doses much higher than those recommended in human therapy (more than 10 times therapeutic dose) for precautionary purposes, the use of the product is contraindicated during pregnancy. Since the drug passes into breast milk, it is not recommended to use it during feeding.
Source: Farmadati
